Clinical trial
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With…
NCT00026377 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00026377 |
|---|---|
| Title | SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer |
| Official title | A Phase I Study Of SU5416 With Androgen Ablation And Radiation In Patients With Intermediate and Advanced Stage Prostate Cancer |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | bicalutamide, flutamide, goserelin acetate, leuprolide acetate, SU5416, radiation therapy |
| Enrollment | 3 |
| Start date | Nov 1, 2001 |
| Primary completion | Mar 1, 2002 |
| Completion | Apr 1, 2003 |
| First posted | Feb 6, 2004 |
| Last update posted | Sep 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: